These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Kwo PY; Cohen SM; Lim JK Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906 [TBL] [Abstract][Full Text] [Related]
7. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity. Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ; Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419 [TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity of azathioprine in renal transplant recipients. Ramalho HJ; Terra EG; Cartapatti E; Barberato JB; Alves VA; Gayotto LC; Abbud-Filho M Transplant Proc; 1989 Feb; 21(1 Pt 2):1716-7. PubMed ID: 2652562 [No Abstract] [Full Text] [Related]
9. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy. Tsung I; Dolan R; Lao CD; Fecher L; Riggenbach K; Yeboah-Korang A; Fontana RJ Aliment Pharmacol Ther; 2019 Oct; 50(7):800-808. PubMed ID: 31309615 [TBL] [Abstract][Full Text] [Related]
10. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB; Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867 [TBL] [Abstract][Full Text] [Related]
11. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689 [TBL] [Abstract][Full Text] [Related]
12. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167 [TBL] [Abstract][Full Text] [Related]
14. Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. DePinho RA; Goldberg CS; Lefkowitch JH Gastroenterology; 1984 Jan; 86(1):162-5. PubMed ID: 6689657 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? Delgado J; Muñoz de Bustillo E; Ibarrola C; Colina F; Morales JM; Rodriguez E; Aguado JM; Fuertes A; Gomez MA J Heart Lung Transplant; 1999 Jun; 18(6):607-10. PubMed ID: 10395359 [TBL] [Abstract][Full Text] [Related]
16. [Hepatotoxicity associated with the use of Herbalife]. Jóhannsson M; Ormarsdóttir S; Olafsson S Laeknabladid; 2010 Mar; 96(3):167-72. PubMed ID: 20197595 [TBL] [Abstract][Full Text] [Related]
17. [A clinical analysis of 22 patients with drug-induced liver injury caused by traditional Chinese medicine Periploca forrestii Schltr]. Feng JC; Wang HY; Zhou AQ; Wang DX; Xie Q; Jiang H; Qian GM Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):692-695. PubMed ID: 27788727 [No Abstract] [Full Text] [Related]
18. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients. Shaye OA; Yadegari M; Abreu MT; Poordad F; Simon K; Martin P; Papadakis KA; Ippoliti A; Vasiliauskas E; Tran TT Am J Gastroenterol; 2007 Nov; 102(11):2488-94. PubMed ID: 17764490 [TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Orman ES; Conjeevaram HS; Vuppalanchi R; Freston JW; Rochon J; Kleiner DE; Hayashi PH; Clin Gastroenterol Hepatol; 2011 Jun; 9(6):517-523.e3. PubMed ID: 21356330 [TBL] [Abstract][Full Text] [Related]
20. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. Chertoff J; Alam S; Black M; Elgendy IY BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25471111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]